Schemes that reward GPs for prescribing generics may breach EU law
BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1945 (Published 09 April 2010) Cite this as: BMJ 2010;340:c1945- Clare Dyer
- 1BMJ
A ruling expected next month from the European Court of Justice in Luxembourg could deprive the NHS of millions of pounds in savings on drugs budgets.
If the judges follow the opinion of the court’s advocate general Niilo Jaaskinen, schemes that reward GPs in England and Wales for prescribing cheaper generic drugs instead of branded medicines will be held to breach European Union law.
The European Court was asked to rule on the issue by the High Court in London, which was hearing a challenge by the Association of the British Pharmaceutical Industry (ABPI) …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.